Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9457073
APP PUB NO 20140154265A1
SERIAL NO

14035415

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to replication-competent Arteriviruses having a decreased DUB/deISGylating activity due to a mutation in the PLP2 domain of the non-structural protein nsp2, to their use as a medicament, their use as a vaccine and in prophylaxis, to vaccines comprising such Arteriviruses and to Arteriviral PLP2-ubiquitin complexes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LEIDEN UNIVERSITY MEDICAL CENTERALBINUSDREEF 2 LEIDEN 2333 ZA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
James, Terrence William Grande Pointe, CA 2 1
Kikkert, Marjolein Sassenheim, NL 2 1
Mark, Brian Leonard Winnipeg, CA 2 1
Snijder, Eric John Bodegraven, NL 3 2
van, Kasteren Puck Bertyne Bussum, NL 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00